| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich
|
Zhang, Danmei
|
|
|
18 |
5 |
p. 767-776
|
article
|
| 2 |
Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer: A Prospective Exploratory Study
|
Morimoto, Kenji
|
|
|
18 |
5 |
p. 657-665
|
article
|
| 3 |
Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients
|
Jew, Scott
|
|
|
18 |
5 |
p. 735-747
|
article
|
| 4 |
Comparative Effectiveness of Lurbinectedin for the Treatment of Relapsed Small Cell Lung Cancer in the Post-Platinum Setting: A Real-World Canadian Synthetic Control Arm Analysis
|
Boyne, Devon J.
|
|
|
18 |
5 |
p. 697-705
|
article
|
| 5 |
Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
|
Lee, Arnold
|
|
|
18 |
5 |
p. 801
|
article
|
| 6 |
Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
|
Lee, Arnold
|
|
|
18 |
5 |
p. 793-800
|
article
|
| 7 |
FDA Approvals of Oncology Drugs for Tissue-Agnostic Indications
|
Zettler, Marjorie E.
|
|
|
18 |
5 |
p. 777-792
|
article
|
| 8 |
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer
|
Gouverneur, Amandine
|
|
|
18 |
5 |
p. 717-726
|
article
|
| 9 |
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
|
Witte, Hanno M.
|
|
|
18 |
5 |
p. 749-765
|
article
|
| 10 |
Mutant HRas Signaling and Rationale for Use of Farnesyltransferase Inhibitors in Head and Neck Squamous Cell Carcinoma
|
Wang, Jiayu
|
|
|
18 |
5 |
p. 643-655
|
article
|
| 11 |
Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1
|
Miao, Xin
|
|
|
18 |
5 |
p. 667-684
|
article
|
| 12 |
Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
|
Lin, Lan-Hsi
|
|
|
18 |
5 |
p. 685-695
|
article
|
| 13 |
Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study
|
Mitani, Seiichiro
|
|
|
18 |
5 |
p. 707-715
|
article
|
| 14 |
Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences
|
Barrientos, Jacqueline C.
|
|
|
18 |
5 |
p. 727-734
|
article
|
| 15 |
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial
|
Motzer, Robert J.
|
|
|
18 |
5 |
p. 639-641
|
article
|
Journal description